USE OF TOLL-LIKE RECEPTOR-9 AGONISTS, TOLL-LIKE RECEPTOR-4 ANTAGONISTS, AND/OR NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS FOR THE TREATMENT OF PREVENTION OF TOLL-LIKE RECEPTOR-4-ASSOCIATED DISORDERS

• 收藏
• 分享

专利权人:

STEVEN C. GRIBAR;DAVID J. HACKAM

发明人:

DAVID J. HACKAM,STEVEN C. GRIBAR

申请号：

US13461672

公开号：

US20130072547A1

申请日:

2012.05.01

申请国别(地区):

US

年份:

2013

代理人:

摘要：

The present invention relates to the use of a TLR9 agonist and/or a TLR4 antagonist and/or a NOD2 agonist for treatment or prevention of disorders involving TLR4 activation, such as systemic sepsis and necrotizing enterocolitis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/